UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043884
Receipt number R000050109
Scientific Title A study of metacognitive abilities in patients after traumatic brain injury
Date of disclosure of the study information 2021/12/31
Last modified on 2022/04/11 09:12:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study of metacognitive abilities in patients after traumatic brain injury

Acronym

A study of metacognitive abilities in patients after traumatic brain injury

Scientific Title

A study of metacognitive abilities in patients after traumatic brain injury

Scientific Title:Acronym

A study of metacognitive abilities in patients after traumatic brain injury

Region

Japan


Condition

Condition

traumatic brain injury

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The objective of the study is to evaluate metacognitive ability in patients after traumatic brain injury by using a behavioral task. We also examine whether patients' cognitive ability and brain legions are associated with their metacognitive ability.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Accuracy rate and reaction time of the behavioral task for evaluating patient's metacognitive ability.

Key secondary outcomes

Paced auditory serial addition test: PASAT
Symbol digit modalities test: SDMT
Rey's verbal learning test: RAVLT
Wisconsin card sorting test: WCST
Patient Competency Rating Scale: PCRS
Frontal Systems Behavior Scale: FrSBe
The magnetic resonance images including T1, T2, and FLAIR


Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >=

Gender

Male and Female

Key inclusion criteria

1.Patients between 20 and 60 years old at the time of consent.
2.Those who were diagnosed with traumatic brain injury and were at least over 3 months post-injury.
3.Those patients who gave informed consent based on their own will or the will of a guardian.

Key exclusion criteria

1.Patients who had a history of psychiatric or neurological disorders prior to the diagnosis of traumatic brain injury.
2.Patients who have difficulty performing the behavioral task or neurological test due to severe motor paralysis, aphasia, vision, or hearing impairment, etc.
3.Conditions in which the principal investigator considers not suitable for participation in the study.

Target sample size

42


Research contact person

Name of lead principal investigator

1st name Katsunori
Middle name
Last name Ikoma

Organization

Hokkaido University Hospital

Division name

Department of Rehabilitation Medicine

Zip code

060-8648

Address

N14 W5, Kita-ku, Sapporo

TEL

011-706-6066

Email

ikoma@med.hokudai.ac.jp


Public contact

Name of contact person

1st name Kazuki
Middle name
Last name Yoshida

Organization

Hokkaido University

Division name

Department of Health Sciences

Zip code

060-0812

Address

N12 W5, Kita-ku, Sapporo

TEL

011-706-3414

Homepage URL


Email

ot-k-yoshida@huhp.hokudai.ac.jp


Sponsor or person

Institute

Hokkaido University Hospital

Institute

Department

Personal name



Funding Source

Organization

Japan Science and Technology Agency

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hokkaido University Hospital

Address

N14 W5, Kita-ku, Sapporo

Tel

011-706-6066

Email

ot-k-yoshida@huhp.hokudai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 12 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

28

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 04 Month 27 Day

Date of IRB

2020 Year 04 Month 27 Day

Anticipated trial start date

2021 Year 04 Month 19 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry

2022 Year 03 Month 31 Day

Date trial data considered complete

2022 Year 03 Month 31 Day

Date analysis concluded

2022 Year 06 Month 30 Day


Other

Other related information

Data correction has been completed and is currently being analyzed.


Management information

Registered date

2021 Year 04 Month 10 Day

Last modified on

2022 Year 04 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050109